Clinical Trials
9 trialsNCT04817007 2026-05-08
A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
Bristol-Myers Squibb
Phase 1/2 Active not recruiting
NCT03952039 2025-08-28
FREEDOM2
Celgene
Phase 3 Completed
NCT01420770 2025-03-05
Phase 2 Study of SAR302503 in Patients With Myelofibrosis
Bristol-Myers Squibb
Phase 2 Completed
NCT01420783 2025-03-05
Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
Bristol-Myers Squibb
Phase 2 Completed
NCT01437787 2025-03-05
JAKARTA
Bristol-Myers Squibb
Phase 3 Completed
NCT01523171 2025-03-05
JAKARTA2
Bristol-Myers Squibb
Phase 2 Completed
NCT01585623 2025-03-05
Drug Interaction Study of SAR302503 in Patients With Solid Tumor
Bristol-Myers Squibb
Phase 1 Completed
NCT01836705 2025-03-05
Effect of SAR302503 on ECG Activity in Patients With Solid Tumors
Bristol-Myers Squibb
Phase 1 Completed
NCT03755518 2024-12-12
FREEDOM
Celgene
Phase 3 Terminated